MAPK1 and neoplasm: Recent findings suggest that the MAPK/ERK signaling hub can serve as both a tumor suppressor and a more typical pro-oncogenic signal, with the dominant effect contingent on signal intensity and the specific tissue or context in which the signal becomes aberrantly activated (20).